Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection
Clinical trial NCT04749368 · COMPLETED
Trial details
- NCT number
- NCT04749368
- Sponsor
- Brii Biosciences Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-12
- Primary completion
- 2023-07-04
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.